Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu WJ, Liu P, Lei W, Jia Z, He X, Shi W, et al. Surveillance of SARS-CoV-2 at the Huanan Seafood Market. Nature. 2023:1–3. https://doi.org/10.1038/s41586-023-06043-2.

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edridge AWD, Kaczorowska J, Hoste A, Bakker M, Klein M, Loens K, et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020;26:1691–3.

Article  CAS  PubMed  Google Scholar 

Dijkman R, Jebbink MF, Gaunt E, Rossen JW, Templeton KE, Kuijpers TW, et al. The dominance of human coronavirus OC43 and NL63 infections in infants. J Clin Virol. 2012;53:135–9.

Article  PubMed  Google Scholar 

Anderson EM, Goodwin EC, Verma A, Arevalo CP, Bolton MJ, Weirick ME, et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell. 2021;184:1858–64.e10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet Lond Engl. 2020;395:565–74.

Article  CAS  Google Scholar 

Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell. 2020;181:914–21.e10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arya R, Kumari S, Pandey B, Mistry H, Bihani SC, Das A, et al. Structural insights into SARS-CoV-2 proteins. J Mol Biol. 2021;433:166725.

Article  CAS  PubMed  Google Scholar 

Nguyen NT, Chinn J, Nahmias J, Yuen S, Kirby KA, Hohmann S, et al. Outcomes and mortality among adults hospitalized with COVID-19 at US medical centers. JAMA Netw Open. 2021;4:e210417.

Article  PubMed  PubMed Central  Google Scholar 

Tjendra Y, Al Mana AF, Espejo AP, Akgun Y, Millan NC, Gomez-Fernandez C, et al. Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers. Arch Pathol Lab Med. 2020;144:1465–74.

Article  CAS  PubMed  Google Scholar 

Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184:476–88.e11.

Article  CAS  PubMed  Google Scholar 

Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, et al. Longitudinal analysis reveals that delayed bystander CD8 + T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity. 2021;54:1257–75.e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473–4.

Article  CAS  PubMed  Google Scholar 

Quan C, Li C, Ma H, Li Y, Zhang H. Immunopathogenesis of coronavirus-induced acute respiratory distress syndrome (ARDS): potential infection-associated hemophagocytic lymphohistiocytosis. Clin Microbiol Rev. 2020;34:e00074–20.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J-M, An J. Cytokines, inflammation and pain. Int Anesthesiol Clin. 2007;45:27–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riera Romo M, Pérez‐Martínez D, Castillo Ferrer C. Innate immunity in vertebrates: an overview. Immunology. 2016;148:125–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffmann H-H, Schneider WM, Rice CM. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 2015;36:124–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kotenko SV, Durbin JE. Contribution of type III interferons to antiviral immunity: location, location, location. J Biol Chem. 2017;292:7295–303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levy DE, Marié IJ, Durbin JE. Induction and function of type I and III interferon in response to viral infection. Curr Opin Virol. 2011;1:476–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Channappanavar R, Perlman S. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity. J Clin Invest. 2020;130:6204–13.

Article  PubMed  PubMed Central  Google Scholar 

Kasuga Y, Zhu B, Jang K-J, Yoo J-S. Innate immune sensing of coronavirus and viral evasion strategies. Exp Mol Med. 2021;53:723–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang H, Lyu Y, Hou F. SARS-CoV-2 infection and the antiviral innate immune response. J Mol Cell Biol. 2020;12:963–7.

Article  PubMed  PubMed Central  Google Scholar 

Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.

Article  CAS  PubMed  Google Scholar 

Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020;35:266–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pasrija R, Naime M. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease. Int Immunopharmacol. 2021;90:107225.

Article  CAS  PubMed  Google Scholar 

Streicher F, Jouvenet N. Stimulation of innate immunity by host and viral RNAs. Trends Immunol. 2019;40:1134–48.

Article  CAS  PubMed  Google Scholar 

Schoggins JW. Interferon-stimulated genes: what do they all do? Annu Rev Virol. 2019;6:567–84.

Article  CAS  PubMed  Google Scholar 

Crouse J, Kalinke U, Oxenius A. Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol. 2015;15:231–42.

Article  CAS  PubMed  Google Scholar 

Lokugamage KG, Hage A, de Vries M, Valero-Jimenez AM, Schindewolf C, Dittmann M, et al. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. J Virol. 2020;94. https://doi.org/10.1128/jvi.01410-20.

Diamond MS, Kanneganti T-D. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022;23:165–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santer DM, Li D, Ghosheh Y, Zahoor MA, Prajapati D, Hansen BE, et al. Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity. Nat Commun. 2022;13:6992.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Portela Sousa C, Brites C. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III. Braz J Infect Dis. 2020;24:428–33.

Article  PubMed  PubMed Central  Google Scholar 

Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14:36–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Acharya D, Liu G, Gack MU. Dysregulation of type I interferon responses in COVID-19. Nat Rev Immunol. 2020;20:397–8.

Article  CAS  PubMed